Perceptions of the use of Artificial Intelligence in the diagnosis of skin cancer: An outpatient survey

Author(s):  
K. Lim ◽  
G. Neal‐Smith ◽  
C. Mitchell ◽  
J. Xerri ◽  
P. Chuanromanee
2020 ◽  
Author(s):  
Abdulrahman Takiddin ◽  
Jens Schneider ◽  
Yin Yang ◽  
Alaa Abd-Alrazaq ◽  
Mowafa Househ

BACKGROUND Skin cancer is the most common cancer type affecting humans. Traditional skin cancer diagnosis methods are costly, require a professional physician, and take time. Hence, to aid in diagnosing skin cancer, Artificial Intelligence (AI) tools are being used, including shallow and deep machine learning-based techniques that are trained to detect and classify skin cancer using computer algorithms and deep neural networks. OBJECTIVE The aim of this study is to identify and group the different types of AI-based technologies used to detect and classify skin cancer. The study also examines the reliability of the selected papers by studying the correlation between the dataset size and number of diagnostic classes with the performance metrics used to evaluate the models. METHODS We conducted a systematic search for articles using IEEE Xplore, ACM DL, and Ovid MEDLINE databases following the PRISMA Extension for Scoping Reviews (PRISMA-ScR) guidelines. The study included in this scoping review had to fulfill several selection criteria; to be specifically about skin cancer, detecting or classifying skin cancer, and using AI technologies. Study selection and data extraction were conducted by two reviewers independently. Extracted data were synthesized narratively, where studies were grouped based on the diagnostic AI techniques and their evaluation metrics. RESULTS We retrieved 906 papers from the 3 databases, but 53 studies were eligible for this review. While shallow techniques were used in 14 studies, deep techniques were utilized in 39 studies. The studies used accuracy (n=43/53), the area under receiver operating characteristic curve (n=5/53), sensitivity (n=3/53), and F1-score (n=2/53) to assess the proposed models. Studies that use smaller datasets and fewer diagnostic classes tend to have higher reported accuracy scores. CONCLUSIONS The adaptation of AI in the medical field facilitates the diagnosis process of skin cancer. However, the reliability of most AI tools is questionable since small datasets or low numbers of diagnostic classes are used. In addition, a direct comparison between methods is hindered by a varied use of different evaluation metrics and image types.


Author(s):  
Pawan Sonawane ◽  
Sahel Shardhul ◽  
Raju Mendhe

The vast majority of skin cancer deaths are from melanoma, with about 1.04 million cases annually. Early detection of the same can be immensely helpful in order to try to cure it. But most of the diagnosis procedures are either extremely expensive or not available to a vast majority, as these centers are concentrated in urban regions only. Thus, there is a need for an application that can perform a quick, efficient, and low-cost diagnosis. Our solution proposes to build a server less mobile application on the AWS cloud that takes the images of potential skin tumors and classifies it as either Malignant or Benign. The classification would be carried out using a trained Convolution Neural Network model and Transfer learning (Inception v3). Several experiments will be performed based on Morphology and Color of the tumor to identify ideal parameters.


Author(s):  
Piyush Kumar ◽  
Rishi Chauhan ◽  
Achyut Shankar ◽  
Thompson Stephan

2019 ◽  
Vol 120 ◽  
pp. 114-121 ◽  
Author(s):  
Achim Hekler ◽  
Jochen S. Utikal ◽  
Alexander H. Enk ◽  
Axel Hauschild ◽  
Michael Weichenthal ◽  
...  

2019 ◽  
Vol 8 (3) ◽  
pp. 133-140 ◽  
Author(s):  
Ofer Reiter ◽  
Veronica Rotemberg ◽  
Kivanc Kose ◽  
Allan C. Halpern

10.2196/22909 ◽  
2020 ◽  
Author(s):  
Sarah Haggenmüller ◽  
Eva Krieghoff-Henning ◽  
Tanja Jutzi ◽  
Nicole Trapp ◽  
Lennard Kiehl ◽  
...  

Different mathematical models, Artificial Intelligence approach and Past recorded data set is combined to formulate Machine Learning. Machine Learning uses different learning algorithms for different types of data and has been classified into three types. The advantage of this learning is that it uses Artificial Neural Network and based on the error rates, it adjusts the weights to improve itself in further epochs. But, Machine Learning works well only when the features are defined accurately. Deciding which feature to select needs good domain knowledge which makes Machine Learning developer dependable. The lack of domain knowledge affects the performance. This dependency inspired the invention of Deep Learning. Deep Learning can detect features through self-training models and is able to give better results compared to using Artificial Intelligence or Machine Learning. It uses different functions like ReLU, Gradient Descend and Optimizers, which makes it the best thing available so far. To efficiently apply such optimizers, one should have the knowledge of mathematical computations and convolutions running behind the layers. It also uses different pooling layers to get the features. But these Modern Approaches need high level of computation which requires CPU and GPUs. In case, if, such high computational power, if hardware is not available then one can use Google Colaboratory framework. The Deep Learning Approach is proven to improve the skin cancer detection as demonstrated in this paper. The paper also aims to provide the circumstantial knowledge to the reader of various practices mentioned above.


2021 ◽  
Author(s):  
Harmony Thompson ◽  
Amanda Oakley ◽  
Michael B Jameson ◽  
Adrian Bowling

BACKGROUND Primary care providers, dermatology specialists, and health care access are key components of primary prevention, early diagnosis, and treatment of skin cancer. Artificial intelligence (AI) offers the promise of diagnostic support for nonspecialists, but real-world clinical validation of AI in primary care is lacking. OBJECTIVE We aimed to (1) assess the reliability of an AI-based clinical triage algorithm in classifying benign and malignant skin lesions and (2) evaluate the quality of images obtained in primary care using the study camera (3Gen DermLite Cam v4 or similar). METHODS This was a single-center, prospective, double-blinded observational study with a predetermined study design. We recruited participants with suspected skin cancer in 20 primary care practices who were referred for assessment via teledermatology. A second set of photographs taken using a standardized camera was processed by the AI algorithm. We evaluated the image quality and compared two teledermatologists’ diagnoses by consensus (the “gold standard”) with AI and histology where applicable. RESULTS Our primary outcome assessment stratified 391 skin lesions by management as benign, uncertain, or malignant. Uncertain lesions were not included in the sensitivity and specificity analyses. Uncertain lesions included lesions that had either diagnostic or management uncertainties. For the remaining 242 lesions, the sensitivity was 97.26% (95% CI 93.13%-99.25%) and the specificity was 97.92% (95% CI 92.68%-99.75%). The AI algorithm was compared with the histological diagnoses for 123 lesions. The sensitivity was 100% (95% CI 95.85%-100%) and the specificity was 72.22% (95% CI 54.81%-85.80%). CONCLUSIONS The AI algorithm demonstrates encouraging results, with high sensitivity and specificity, concordant with previous AI studies. It shows potential as a triage tool in conjunction with teledermatology to augment health care and improve access to dermatology. Further real-life studies need to be conducted on a larger scale to assess the reliability, usability, and cost-effectiveness of the algorithm in primary care.


Sign in / Sign up

Export Citation Format

Share Document